Papoff G - Search Results

1

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.

Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A. Giordano C, et al. Among authors: papoff g. Science. 1997 Feb 14;275(5302):960-3. doi: 10.1126/science.275.5302.960. Science. 1997. PMID: 9020075

2

Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.

Cascino I, Fiucci G, Papoff G, Ruberti G. Cascino I, et al. Among authors: papoff g. J Immunol. 1995 Mar 15;154(6):2706-13. J Immunol. 1995. PMID: 7533181

3

Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.

Cascino I, Papoff G, De Maria R, Testi R, Ruberti G. Cascino I, et al. Among authors: papoff g. J Immunol. 1996 Jan 1;156(1):13-7. J Immunol. 1996. PMID: 8598453

4

An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.

Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G. Papoff G, et al. J Immunol. 1996 Jun 15;156(12):4622-30. J Immunol. 1996. PMID: 8648105

5

Fas splicing variants and their effect on apoptosis.

Ruberti G, Cascino I, Papoff G, Eramo A. Ruberti G, et al. Among authors: papoff g. Adv Exp Med Biol. 1996;406:125-34. doi: 10.1007/978-1-4899-0274-0_13. Adv Exp Med Biol. 1996. PMID: 8910678 Review. No abstract available.

6

Soluble Fas/Apo-1 splicing variants and apoptosis.

Cascino I, Papoff G, Eramo A, Ruberti G. Cascino I, et al. Among authors: papoff g. Front Biosci. 1996 Jan 1;1:d12-8. doi: 10.2741/A112. Front Biosci. 1996. PMID: 9159204 Review.

7

Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome.

Baiocchi RA, Khatri VP, Lindemann MJ, Ross ME, Papoff G, Caprio AJ, Caprio TV, Fenstermaker R, Ruberti G, Bernstein ZP, Caligiuri MA. Baiocchi RA, et al. Among authors: papoff g. Blood. 1997 Sep 1;90(5):1737-46. Blood. 1997. PMID: 9292506 Free article.

8

Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B.

Häusler P, Papoff G, Eramo A, Reif K, Cantrell DA, Ruberti G. Häusler P, et al. Among authors: papoff g. Eur J Immunol. 1998 Jan;28(1):57-69. doi: 10.1002/(SICI)1521-4141(199801)28:01<57::AID-IMMU57>3.0.CO;2-8. Eur J Immunol. 1998. PMID: 9485186 Free article.

9

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.

Prasad NK, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, Kaveri SV. Prasad NK, et al. Among authors: papoff g. J Immunol. 1998 Oct 1;161(7):3781-90. J Immunol. 1998. PMID: 9759905

10

The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.

Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L. Tolomeo M, et al. Among authors: papoff g. Cell Death Differ. 1998 Sep;5(9):735-42. doi: 10.1038/sj.cdd.4400406. Cell Death Differ. 1998. PMID: 10200532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters